O

Ottawa Memory Clinic | Ottawa, Canada

Research site

(Unclaimed)

Location

1600 Carling Ave, Ottawa, Ontario, Canada

Site insights

Top conditions

Top treatments

Simufilam

Semaglutide

PTI-125

Semagludtide

LY3002813

LY3372689

Remternetug

KarXT

Donanemab

KarX

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 16 total trials

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting

Alzheimer Disease

Drug: Donanemab

Drug: Placebo

A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting

Alzheimer's Disease

Drug: Placebo

Drug: Remternetug

Locations recently updated

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 1)

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

Enrolling

Alzheimer's Disease

Other: Placebo

Drug: KarXT

A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)

Researchers want to learn if giving MK-1167 (the study medicine) along with acetylcholinesterase inhibitor (AChEI) therapy can improve symptoms of Al...

Active, not recruiting

Alzheimer Disease

Dementia

Drug: MK-1167

Drug: Placebo

Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease

The goal of this clinical trial is to test SNK01 in participants with moderate Alzheimer's Disease. The main questions it aims to answer are:1. Is SN...

Enrolling

Moderate Alzheimer Disease

Biological: SNK01

Other: Placebo